메뉴 건너뛰기




Volumn 60, Issue 11, 2014, Pages 1409-1418

Association of 1,5-anhydroglucitol with diabetes and microvascular conditions

Author keywords

[No Author keywords available]

Indexed keywords

1,5 ANHYDROSORBITOL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; 1,5-ANHYDROGLUCITOL; DEOXYGLUCOSE; GLYCOSYLATED HEMOGLOBIN;

EID: 84908614913     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2014.229427     Document Type: Article
Times cited : (57)

References (36)
  • 1
    • 84892649479 scopus 로고    scopus 로고
    • Standards of medical care in diabetes-2014
    • American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care 2014;37(Suppl 1):S14-80.
    • (2014) Diabetes Care , vol.37 , pp. S14-80
    • American Diabetes Association1
  • 2
    • 34547224132 scopus 로고    scopus 로고
    • Short-term variability in measures of glycemia and implications for the classification of diabetes
    • Selvin E, Crainiceanu CM, Brancati FL, Coresh J. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007;167:1545-51.
    • (2007) Arch Intern Med , vol.167 , pp. 1545-1551
    • Selvin, E.1    Crainiceanu, C.M.2    Brancati, F.L.3    Coresh, J.4
  • 3
    • 0037015288 scopus 로고    scopus 로고
    • Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: Effects of short- and long-term simvastatin treatment
    • Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 2002;106:1211-8.
    • (2002) Circulation , vol.106 , pp. 1211-1218
    • Ceriello, A.1    Taboga, C.2    Tonutti, L.3    Quagliaro, L.4    Piconi, L.5    Bais, B.6
  • 4
    • 0034833888 scopus 로고    scopus 로고
    • Postprandial blood glucose. American diabetes association
    • American Diabetes Association. Postprandial blood glucose. American diabetes association. Diabetes Care 2001;24:775-8.
    • (2001) Diabetes Care , vol.24 , pp. 775-778
    • American Diabetes Association1
  • 5
    • 0036783237 scopus 로고    scopus 로고
    • Fasting and postchallenge glycemia and cardiovascular disease risk: The framingham offspring study
    • Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002;25:1845-50.
    • (2002) Diabetes Care , vol.25 , pp. 1845-1850
    • Meigs, J.B.1    Nathan, D.M.2    D'Agostino, R.B.3    Wilson, P.W.4
  • 7
    • 0027984450 scopus 로고
    • Serum 1,5- anhydroglucitol (1,5 ag): New clinical marker for glycemic control
    • Yamanouchi T, Akanuma Y. Serum 1,5- anhydroglucitol (1,5 ag): new clinical marker for glycemic control. Diabetes Res Clin Pract 1994; 24(Suppl):S261-8.
    • (1994) Diabetes Res Clin Pract , vol.24 , pp. S261-S268
    • Yamanouchi, T.1    Akanuma, Y.2
  • 8
    • 38149030947 scopus 로고    scopus 로고
    • 1,5-anhydroglucitol (glycomark) as a marker of short-term glycemic control and glycemic excursions
    • Dungan KM. 1,5-anhydroglucitol (glycomark) as a marker of short-term glycemic control and glycemic excursions. Expert Rev Mol Diagn 2008; 8:9-19.
    • (2008) Expert Rev Mol Diagn , vol.8 , pp. 9-19
    • Dungan, K.M.1
  • 9
    • 0029941887 scopus 로고    scopus 로고
    • Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control
    • Yamanouchi T, Ogata N, Tagaya T, Kawasaki T, Sekino N, Funato H, et al. Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control. Lancet 1996;347:1514-8.
    • (1996) Lancet , vol.347 , pp. 1514-1518
    • Yamanouchi, T.1    Ogata, N.2    Tagaya, T.3    Kawasaki, T.4    Sekino, N.5    Funato, H.6
  • 10
    • 0024591825 scopus 로고
    • The atherosclerosis risk in communities (aric) study: Design and objectives. The aric investigators
    • The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989;129:687-702.
    • (1989) Am J Epidemiol , vol.129 , pp. 687-702
  • 12
    • 79951726391 scopus 로고    scopus 로고
    • Comparison of two assays for serum 1,5-anhydroglucitol
    • Selvin E, Rynders GP, Steffes MW. Comparison of two assays for serum 1,5-anhydroglucitol. Clin Chim Acta 2011;412:793-5.
    • (2011) Clin Chim Acta , vol.412 , pp. 793-795
    • Selvin, E.1    Rynders, G.P.2    Steffes, M.W.3
  • 13
    • 0033503919 scopus 로고    scopus 로고
    • Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the atherosclerosis risk in communities study
    • Hubbard LD, Brothers RJ, King WN, Clegg LX, Klein R, Cooper LS, et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 1999;106:2269-80.
    • (1999) Ophthalmology , vol.106 , pp. 2269-2280
    • Hubbard, L.D.1    Brothers, R.J.2    King, W.N.3    Clegg, L.X.4    Klein, R.5    Cooper, L.S.6
  • 14
    • 0036141656 scopus 로고    scopus 로고
    • Reliability of retinal photography in the assessment of retinal microvascular characteristics: The atherosclerosis risk in communities study
    • Couper DJ, Klein R, Hubbard LD, Wong TY, Sorlie PD, Cooper LS, et al. Reliability of retinal photography in the assessment of retinal microvascular characteristics: the Atherosclerosis Risk in Communities Study. Am J Ophthalmol 2002;133: 78-88.
    • (2002) Am J Ophthalmol , vol.133 , pp. 78-88
    • Couper, D.J.1    Klein, R.2    Hubbard, L.D.3    Wong, T.Y.4    Sorlie, P.D.5    Cooper, L.S.6
  • 15
    • 39649088467 scopus 로고    scopus 로고
    • Relation between fasting glucose and retinopathy for diagnosis of diabetes: Three population-based cross-sectional studies
    • Wong TY, Liew G, Tapp RJ, Schmidt MI, Wang JJ, Mitchell P, et al. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet 2008;371:736-43.
    • (2008) Lancet , vol.371 , pp. 736-743
    • Wong, T.Y.1    Liew, G.2    Tapp, R.J.3    Schmidt, M.I.4    Wang, J.J.5    Mitchell, P.6
  • 17
    • 0038691972 scopus 로고    scopus 로고
    • Low-grade systemic inflammation and the development of type 2 diabetes: The atherosclerosis risk in communities study
    • Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes 2003;52:1799-805.
    • (2003) Diabetes , vol.52 , pp. 1799-1805
    • Duncan, B.B.1    Schmidt, M.I.2    Pankow, J.S.3    Ballantyne, C.M.4    Couper, D.5    Vigo, A.6
  • 18
    • 77953464602 scopus 로고    scopus 로고
    • Measurement of hba1c from stored whole blood samples in the atherosclerosis risk in communities study
    • Selvin E, Coresh J, Zhu H, Folsom A, Steffes MW. Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities study. J Diabetes 2010;2:118-24.
    • (2010) J Diabetes , vol.2 , pp. 118-124
    • Selvin, E.1    Coresh, J.2    Zhu, H.3    Folsom, A.4    Steffes, M.W.5
  • 19
    • 0020539888 scopus 로고
    • Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency
    • Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983;29:1075-80.
    • (1983) Clin Chem , vol.29 , pp. 1075-1080
    • Siedel, J.1    Hagele, E.O.2    Ziegenhorn, J.3    Wahlefeld, A.W.4
  • 20
    • 0015348189 scopus 로고
    • Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
    • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18: 499-502.
    • (1972) Clin Chem , vol.18 , pp. 499-502
    • Friedewald, W.T.1    Levy, R.I.2    Fredrickson, D.S.3
  • 25
    • 0020417197 scopus 로고
    • A short questionnaire for the measurement of habitual physical activity in epidemiological studies
    • Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936-42.
    • (1982) Am J Clin Nutr , vol.36 , pp. 936-942
    • Baecke, J.A.1    Burema, J.2    Frijters, J.E.3
  • 27
    • 0030069896 scopus 로고    scopus 로고
    • Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
    • Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15:361-87.
    • (1996) Stat Med , vol.15 , pp. 361-387
    • Harrell, F.E.1    Lee, K.L.2    Mark, D.B.3
  • 28
    • 78649477601 scopus 로고    scopus 로고
    • Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
    • Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011;30:11-21.
    • (2011) Stat Med , vol.30 , pp. 11-21
    • Pencina, M.J.1    D'Agostino, R.B.2    Steyerberg, E.W.3
  • 29
    • 84870321341 scopus 로고    scopus 로고
    • Associations of alternative markers of glycemia with hemoglobin a(1c) and fasting glucose
    • Juraschek SP, Steffes MW, Selvin E. Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose. Clin Chem 2012;58:1648-55.
    • (2012) Clin Chem , vol.58 , pp. 1648-1655
    • Juraschek, S.P.1    Steffes, M.W.2    Selvin, E.3
  • 30
    • 84899585626 scopus 로고    scopus 로고
    • Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: A prospective cohort analysis of the atherosclerosis risk in communities (aric) study
    • Selvin E, Rawlings AM, Grams M, Klein R, Sharrett AR, Steffes M, Coresh J. Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diab Endocrinol 2014;2:279-88.
    • (2014) Lancet Diab Endocrinol , vol.2 , pp. 279-288
    • Selvin, E.1    Rawlings, A.M.2    Grams, M.3    Klein, R.4    Sharrett, A.R.5    Steffes, M.6    Coresh, J.7
  • 32
    • 84860897474 scopus 로고    scopus 로고
    • A study on the association of serum 1,5- anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in china
    • Wang Y, Zhang YL, Wang YP, Lei CH, Sun ZL. A study on the association of serum 1,5- anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China. Diabetes Metab Res Rev 2012;28:357-62.
    • (2012) Diabetes Metab Res Rev , vol.28 , pp. 357-362
    • Wang, Y.1    Zhang, Y.L.2    Wang, Y.P.3    Lei, C.H.4    Sun, Z.L.5
  • 33
    • 79251631302 scopus 로고    scopus 로고
    • Correlation between baseline serum 1,5-anhydroglucitol levels and 2-hour post-challenge glucose levels during oral glucose tolerance tests
    • Goto M, Yamamoto-Honda R, Shimbo T, Goto A, Terauchi Y, Kanazawa Y, Noda M. Correlation between baseline serum 1,5-anhydroglucitol levels and 2-hour post-challenge glucose levels during oral glucose tolerance tests. Endocr J 2011; 58:13-7.
    • (2011) Endocr J , vol.58 , pp. 13-17
    • Goto, M.1    Yamamoto-Honda, R.2    Shimbo, T.3    Goto, A.4    Terauchi, Y.5    Kanazawa, Y.6    Noda, M.7
  • 34
    • 84865113079 scopus 로고    scopus 로고
    • Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in type 2 diabetes
    • Kim WJ, Park CY, Park SE, Rhee EJ, Lee WY, Oh KW, et al. Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in type 2 diabetes. Diabet Med 2012;29:1184-90.
    • (2012) Diabet Med , vol.29 , pp. 1184-1190
    • Kim, W.J.1    Park, C.Y.2    Park, S.E.3    Rhee, E.J.4    Lee, W.Y.5    Oh, K.W.6
  • 36
    • 79958016689 scopus 로고    scopus 로고
    • Serum 1,5-anhydro-dglucitol levels predict first-ever cardiovascular disease: An 11-year population-based cohort study in Japan, the suita study
    • Watanabe M, Kokubo Y, Higashiyama A, Ono Y, Miyamoto Y, Okamura T. Serum 1,5-anhydro-Dglucitol levels predict first-ever cardiovascular disease: an 11-year population-based cohort study in Japan, the Suita study. Atherosclerosis 2011;216:477-83.
    • (2011) Atherosclerosis , vol.216 , pp. 477-483
    • Watanabe, M.1    Kokubo, Y.2    Higashiyama, A.3    Ono, Y.4    Miyamoto, Y.5    Okamura, T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.